JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹16 Cr | ₹17 Cr | ₹20 Cr | ₹17 Cr | ₹17 Cr |
What is the latest Contingent Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹17 Cr |
| Mar2021 | ₹17 Cr |
How is Contingent Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | -0.45 | |
| Mar2024 | ₹17 Cr | -15.25 | |
| Mar2023 | ₹20 Cr | 17.75 | |
| Mar2022 | ₹17 Cr | -0.19 | |
| Mar2021 | ₹17 Cr | - | |
Compare Contingent Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹477.8 Cr | 0.2% | -9% | -15.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,131.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,862.0 Cr | 2.9% | 1.8% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,254.0 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹121,198.0 Cr | 0.2% | -0.2% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,083.0 Cr | 0.9% | 4.8% | -3.2% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | 0.2% |
-9% |
-15.7% |
| SENSEX | 1% |
0.3% |
6.7% |
You may also like the below Video Courses